Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Paraesthesia oral, Peripheral swelling
Clinical narrative: Tingling of lips; Numbness of top of head/ Numbness of ears; Progressing to numbness and weakness of knees; Progressing to swelling of legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021417570 (Pfizer).  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 14:00 (Lot number: ER8734) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism (Hashimoto's)" (unspecified if ongoing); "Pet and seasonal allergies" (unspecified if ongoing); "Pet and seasonal allergies" (unspecified if ongoing); "Interstitial Cystitis" (unspecified if ongoing); "Shellfish, eggs, candy canes/ sensitive to acidy foods and soy products" (unspecified if ongoing); "Acidy foods and soy products" (unspecified if ongoing); "latex" (unspecified if ongoing); "sulfa" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXIN; CALCIUM; VIT D3; PEPCID AC. Past drug history included: Novocaine, reaction(s): "Sensitive", notes: Allergies to medications, food, or other products; Clindamycin, reaction(s): "Sensitive", notes: Allergies to medications; Erythromycin, reaction(s): "Sensitive", notes: Allergies to medications; Pcn, reaction(s): "Sensitive", notes: Allergies to medications; Lincomycin, reaction(s): "Sensitive", notes: Allergies to medications; Ceclor, reaction(s): "Sensitive", notes: Allergies to medications. The following information was reported: PARAESTHESIA ORAL (non-serious) with onset 05Apr2021 02:45, outcome "recovered" (2021), described as "Tingling of lips"; HYPOAESTHESIA (non-serious) with onset 05Apr2021 02:45, outcome "recovered" (2021), described as "Numbness of top of head/ Numbness of ears"; ASTHENIA (non-serious) with onset 05Apr2021 02:45, outcome "recovered" (2021), described as "Progressing to numbness and weakness of knees"; PERIPHERAL SWELLING (non-serious) with onset 05Apr2021 02:45, outcome "recovered" (2021), described as "Progressing to swelling of legs". The events "tingling of lips", "numbness of top of head/ numbness of ears", "progressing to numbness and weakness of knees" and "progressing to swelling of legs" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of paraesthesia oral, hypoaesthesia, asthenia, peripheral swelling.   Additional information: It was reported that, tingling of lips, numbness of ears, progressing to numbness and weakness of knees, progressing to swelling of legs, progressing to numbness of top of head.  She stayed 30 minutes after her vaccine and symptoms started on her drive home so she pulled into the parking garage at a local hospital she was passing and went into the ER.  By that time her knees were involved. While waiting in the ER her legs swelled and the top of her head was numb. It started to reverse after they gave her 50 mg of Benadryl. Patient did not receive any other vaccines within 4 weeks prior and received other medications (Levothyroxine, Multivit, Calcium, Vit D3, Pepcid) 2 weeks prior to the COVID vaccine. Patient was allergic to medications, food, or other products: shellfish, eggs, candy canes, sensitive to novacaine, erythromycin, lincomycin, clindamycin, ceclor, PCN, sulfa, latex, acidy foods and soy products. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination.  No follow-up attempts are possible. No further information is expected.